PNC-27 — Vendor Pricing & Purity Guide
Research Overview
PNC-27 is a synthetic peptide that contains a p53 binding domain attached to a membrane-penetrating sequence. It selectively targets cancer cells by binding to HDM-2 (a p53 inhibitor overexpressed in cancer cells), causing membrane disruption and necrosis specifically in malignant cells while sparing normal cells.
PNC-27 represents an emerging approach to cancer therapy — using peptides to selectively destroy tumor cells based on their surface protein expression differences from normal cells.
Key Research Findings
- •Selectively killed cancer cells while sparing normal cells in vitro and in vivo
- •Targeted HDM-2 overexpression — a feature common to many cancer types
- •Induced cancer cell membrane disruption and necrosis
- •Active against multiple cancer cell lines including pancreatic, breast, and leukemia
Research Dosage Protocols
PNC-27 is an experimental anti-cancer peptide. Research is preclinical. It is supplied as lyophilized powder for in vitro and animal studies.
For research reference only. Not medical advice. Not for human consumption.
Price Comparison (6 products from 6 vendors)
| Vendor | Price | Stock |
|---|---|---|
| Polaris Peptides | $150.00 $15.00/mg 10mg lyophilized | Out |
| Core Peptides | $138.00 $27.60/mg 5mg vial | In Stock |
| BioLongevity Labs | $279.97 $28.00/mg 10mg vial | In Stock |
| Biotech Peptides | $142.00 $28.40/mg 5mg vial | In Stock |
| Peptide Sciences | $150.00 $30.00/mg 5mg lyophilized | In Stock |
| Pure Rawz | $163.40 $32.68/mg 5mg vial | In Stock |
Frequently Asked Questions
What is PNC-27?
PNC-27 is an anti-cancer peptide that selectively kills tumor cells by targeting HDM-2, a protein overexpressed in cancer. It spares normal cells.